Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma

Proteome Science

Volumn 6, Issue , 2008, Pages

  Chen, Yeng ^a   Lim, Boon Kiong ^a   Peh, Suat Cheng ^a   Abdul Rahman, Puteri Shafinaz ^a   Hashim, Onn Haji ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; CLUSTERIN; FETUIN A; GLYCOPROTEIN; HAPTOGLOBIN; LEUCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL OVARY CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GERM LINE OVARY CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; TISSUE LEVEL; UPREGULATION;

EID: 48949106841     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-6-20     Document Type: Article

References (45)

1. Gabay J Kushner I Acute-phase proteins and other systemic responses to inflammation N Engl J Med 1999, 340:448-454 10.1056/NEJM199902113400607 9971870
2. Adkins JN Varnum SM Auberry KJ Moore RJ Angell NH Smith RD Springer DL Pounds JG Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry Mol Cell Proteomics 2002, 1:947-955 10.1074/mcp.M200066-MCP200 12543931
3. Wang YY Cheng P Chan DW A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis Proteomics 2003, 3:243-248 10.1002/pmic.200390036 12627376
4. Pieper R Gatlin CL Makusky AJ Russo PS Schatz CR Miller SS Su Q McGrath AM Estock MA Parmar PP Zhao M Huang ST Zhou J Wang F Esquer-Blasco R Anderson NL Taylor J Steiner S The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins Proteomics 2003, 3:1345-1364 10.1002/pmic.200300449 12872236
5. Veenstra TD Conrads TP Hood BL Avellino AM Ellenbogen RG Morrison RS Biomarkers: Mining the biofluid proteome Mol Cell Proteomics 2005, 4:409-418 10.1074/mcp.M500006-MCP200 15684407
6. Linke T Doraiswamy S Harrison EH Rat plasma proteomics: Effects of abundant protein depletion on proteomic analysis J Chromatogr B Analyt Technol Biomed Life Sci 2007, 849:273-281 10.1016/j.jchromb.2006.11.051 17188586
7. Doustjalali SR Yusof R Yip CH Looi LM Pillay B Hashim OH Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors Electrophoresis 2004, 25:2392-2401 10.1002/elps.200305950 15274022
8. Doustjalali SR Yusof R Govindasamy GK Bustam AZ Pillay B Hashim OH Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression J Med Invest 2006, 53:20-28 10.2152/ jmi.53.20 16537992
9. Abdul-Rahman PS Lim BK Hashim OH Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: Analysis using 2-DE with silver staining and lectin detection methods Electrophoresis 2007, 28:1989-1996 10.1002/elps.200600629 17503403
10. Yong PH Junit SM Harun F Hashim OH Patients with congenital hypothyroidism demonstrate different altered expression of plasma fibrinogen and haptoglobin polypeptide chains Clin Biochem 2006, 39:126-132 10.1016/j.clinbiochem.2005.11.017 16412408
11. Rubin SC Sutton GP Ovarian carcinoma Philadelphia: Lippincott, Williams & Wilkins 2001
12. Jordan-Starck TC Witte DP Aronow B Harmony JAK Apolipoprotein J: A membrane policeman? Curr Opin Lipidol 1992, 3:75-85 10.1097/ 00041433-199204000-00004
13. Kang YK Hong SW Lee HS Kim WH Overexpression of clusterin in human hepatocellular carcinoma Hum Pathol 2004, 35:1340-1346 10.1016/ j.humpath.2004.07.021 15668890
14. Busam KJ Zhao H Coit DG Kucukgol D Jungbluth AA Nobrega J Viale A Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling J Invest Dermatol 2005, 124:412-419 10.1111/ j.0022-202X.2004.23600.x 15675962
15. Rodriguez-Pineiro AM de la Cadena MP Lopez-Saco A Rodriguez-Berrocal FJ Differential expression of serum clusterin isoforms in colorectal cancer Mol Cell Proteomics 2006, 5:1647-1657 10.1074/mcp.M600143-MCP200 16854844
16. Miyake H Gleave M Kamidono S Hara I Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence Urology 2002, 59:150-154 10.1016/ S0090-4295(01)01484-4 11796313
17. Lae ME Ahmed I Macon WR Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma Am J Clin Pathol 2002, 118:773-779 10.1309/N3GJ-N7A3-T98G-RYJL 12428799
18. Xie D Lau SH Sham JST Wu QL Fang Y Liang LZ Che LH Zeng YX Guan XY Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma Cancer 2005, 103:277-283 10.1002/cncr.20765 15578711
19. Lemansky P Brix K Herzog V Subcellular distribution, secretion, and posttranslational modifications of clusterin in thyrocytes Exp Cell Res 1999, 251:147-155 10.1006/excr.1999.4555 10438580
20. Kondi-Pafiti A Smyrniotis V Frangou M Papayanopoulou A Englezou M Deligeorgi H Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases Acta Oncol 2000, 39:753-756 10.1080/028418600750063848 11130016
21. Ros-Bullon MR Sanchez-Pedreno P Martinez-Liarte H Serum ceruloplasmin in melanoma patients Anticancer Res 2001, 21:629-632 11299817
22. Casamassima A Addabbo L Caporusso L Lorusso V Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients Int J Biol Markers 1991, 6:183-187 1791312
23. Pejovic M Djordjevic V Ignjatovic I Stamenic T Stefanovic V Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers Int Urol Nephrol 1997, 29:427-432 10.1007/BF02551108 9405999
24. Agroyannis B Dalamangas A Dardouphas K Fortoynas C Saloum G Stringou E Tzanatos H Koutsikos D Papadimitriou J Serum transferrin and ceruloplasmin in patients with cancer of the gastrointestinal and other systems Anticancer Res 1994, 14:2201-2203 7840524
25. Arumanayagam M Wong FW Rogers M Swaminathan R Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma Gynecol Obstet Invest 1993, 35:175-178 8505012
26. Kirchheimer JC Kolbl H Tatra G Binder BR Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignancies Eur J Clin Invest 1990, 20:79-84 10.1111/j.1365-2362.1990.tb01795.x 1690655
27. Harris ED A requirement for copper in angiogenesis Nutr Rev 2004, 62:60-64 10.1301/nr.2004.feb.60-64 15080367
28. Travis J Salvesen GS Human plasma proteinase inhibitors Ann Rev Biochem 1983, 52:655-709 10.1146/annurev.bi.52.070183.003255 6193754
29. Black WC Haggstrom DA Welch HG All-cause mortality in randomized trials of cancer screening J Natl Cancer Inst 2002, 94:167-173 11830606
30. Tokes ZA Gendler SJ Dermer GB The synthesis of a proteinase inhibitor, alpha-1-antichymotrypsin, by human breast epithelial cells J Supramol Struct Cell Biochem 1981, 17:69-77 10.1002/jsscb.380170108 6895651
31. Gendler SJ Dermer GB Silverman LM Tokes ZA Synthesis of alpha 1-antichymotrypsin and alpha 1-acid glycoprotein by human breast epithelial cells Cancer Res 1982, 42:4567-4573 6290040
32. Sveger T Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants N Engl J Med 1976, 294:1316-1321 1083485
33. Vejda S Posovszky C Zelzer S Peter B Bayer E Gelbmann D Schulte-Hermann R Gerner C Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis Mol Cell Proteomics 2002, 1:387-393 10.1074/mcp.M200004-MCP200 12118080
34. Mueller WK Handschumacher R Wade ME Serum haptoglobin in patients with ovarian malignancies Obstet Gynecol 1971, 38:427-435 4999312
35. Thompson S Dargan E Turner GA Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer Cancer Lett 1992, 66:43-48 10.1016/0304-3835(92)90278-4 1451094
36. Ye B Cramer DW Skates SJ Gygi SP Pratomo V Fu L Horick NK Licklider LJ Schorge JO Berkowitz RS Mok SC Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry Clin Cancer Res 2003, 9:2904-2911 12912935
37. Ahmed N Barker G Oliva KT Hoffmann P Riley C Reeve S Smith AL Kemp BE Quinn MA Rice GE Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer Br J Cancer 2004, 91:129-140 10.1038/sj.bjc.6601882 15199385
38. Baskies AM Chretien PB Weiss JF Makuch RW Beveridge RA Catalona WJ Spiegel HE Serum glycoproteins in cancer patients: First report of correlations with in vitro and in vivo parameters of cellular immunity Cancer 1980, 45:3050-3060 10.1002/ 1097-0142(19800615)45:12<3050::AID-CNCR2820451229>3.0.CO;2-8 7388749
39. Kalabay L Jakab L Prohaszka Z Fust G Benko Z Telegdy L Lorincz Z Zavodszky P Arnaud P Fekete B Human fetuin/alpha 2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer Eur J Gastroenterol Hepatol 2002, 14:389-394 10.1097/00042737-200204000-00009 11943951
40. Saito K Tanaka T Kanda H Ebisuno Y Izawa D Kawamoto S Okubo K Miyasaka M Gene expression profiling of mucosal addressin cell adhesion molecule-1(+) high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker J Immunol 2002, 168:1050-1059 11801638
41. Bini A Itoh Y Kudryk BJ Nagase H Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): Hydrolysis of the gamma Gly 404-Ala 405 peptide bond Biochemistry 1996, 35:13056-13063 10.1021/ bi960730c 8855941
42. Moss EL Hollingworth J Reynolds TM The role of CA125 in clinical practice J Clin Pathol 2005, 58:308-312 1770590 15735166 10.1136/ jcp.2004.018077
43. Heukeshoven J Dernick R Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels Electrophoresis 1988, 9:28-32 10.1002/elps.1150090106 2466645
44. Shevchenko A Wilm M Vorm O Mann M Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal Chem 1996, 68:850-858 10.1021/ac950914h 8779443
45. Sanchez JC Appel RD Golaz O Pasquali C Ravier F Bairoch A Hochstrasser DF Inside SWISS-2DPAGE database Electrophoresis 1995, 16:1131-1151 10.1002/elps.11501601190 7498157